Atalar E, Haznedaroğlu I, Aytemir K, Aksöyek S, Ovünç K, Oto A, Ozmen F
Hacettepe University Faculty of Medicine, Department of Cardiology, Ankara, Turkey.
Clin Cardiol. 2001 Feb;24(2):159-64. doi: 10.1002/clc.4960240211.
Adhesion molecules are known to be important in the regulation of endothelial cell and platelet functions. Increased platelets P-selectin expression is a marker of stent thrombosis after uncoated stent placement.
The aim of this study was to compare the effects of intracoronary placement of phosphorylcholine (PC)-coated, versus heparin-coated, versus uncoated stents on platelets and endothelial activity.
Thirty patients (age 55 +/- 10, 27 men) with significant proximal left anterior descending coronary artery stenoses were randomized to elective implantation of PC-coated, versus heparin-coated, versus uncoated stents. Following stent placement, intravenous heparin and aspirin plus ticlopidine were administered. Venous plasma soluble E-selectin, sP-selectin, and intercellular adhesion molecule-l levels were measured before the procedure and 24 and 48 h thereafter as markers of platelet and endothelial cell activation. Patients were excluded if they had a disease known to influence platelet and endothelial cell function.
Plasma sP-selectin levels decreased significantly after implantation of PC- and heparin-coated stents (p = 0.04), but remained unchanged in patients randomized to uncoated stents. Plasma sE-selectin levels increased significantly after uncoated stent placement (p = 0.04) and remained unchanged after coated stent implantation.
In patients treated with combined antiplatelet therapy, implantation of PC- and heparin-coated stents decreased platelet activity without activating endothelial cells, whereas placement of uncoated stents led to endothelial activation without changing platelet activity. These results suggest that PC-coated and heparin-coated stents may be advantageous in limiting thrombotic complications.
已知黏附分子在调节内皮细胞和血小板功能方面很重要。血小板P-选择素表达增加是未涂层支架置入后支架血栓形成的一个标志物。
本研究的目的是比较冠状动脉内植入磷酰胆碱(PC)涂层支架、肝素涂层支架和未涂层支架对血小板和内皮活性的影响。
30例(年龄55±10岁,27例男性)左前降支近端冠状动脉严重狭窄患者被随机分为择期植入PC涂层支架、肝素涂层支架或未涂层支架。支架置入后,给予静脉肝素以及阿司匹林加噻氯匹定。在手术前、术后24小时和48小时测量静脉血浆可溶性E-选择素、可溶性P-选择素和细胞间黏附分子-1水平,作为血小板和内皮细胞活化的标志物。如果患者患有已知会影响血小板和内皮细胞功能的疾病,则将其排除。
植入PC涂层支架和肝素涂层支架后,血浆可溶性P-选择素水平显著降低(p = 0.04),但随机分配到未涂层支架组的患者该水平保持不变。未涂层支架置入后,血浆可溶性E-选择素水平显著升高(p = 0.04),而涂层支架植入后该水平保持不变。
在接受联合抗血小板治疗的患者中,植入PC涂层支架和肝素涂层支架可降低血小板活性而不激活内皮细胞,而未涂层支架的置入则导致内皮激活而不改变血小板活性。这些结果表明,PC涂层支架和肝素涂层支架在限制血栓形成并发症方面可能具有优势。